Literature DB >> 14510992

A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the U.K.

B L Diffey1.   

Abstract

BACKGROUND: Concern has been expressed for many years in the medical and regulatory literature about the adverse health effects, especially melanoma, from the use of sunbeds for cosmetic tanning.
OBJECTIVES: To estimate the mortality from melanoma as a result of the use of sunbeds for cosmetic tanning in the U.K.
METHODS: A model using a Monte Carlo random sampling technique was developed to estimate human ultraviolet exposure to both sunlight and sunbeds, and these data were used to predict the contribution of sunbeds to melanoma mortality in the U.K.
RESULTS: The mortality from melanoma due to sunbed use each year in the U.K. is estimated to be about 100 deaths.
CONCLUSIONS: Sunbed use could be regarded as a relatively minor self-imposed detriment to public health compared with other voluntary 'pleasurable' activities associated with significant mortality, such as smoking and drinking alcohol. While cosmetic tanning using sunbeds should be discouraged, prohibition is not warranted especially as exposure to the sun, which cannot be regulated, remains the major contributory factor to the risk of melanoma.

Entities:  

Mesh:

Year:  2003        PMID: 14510992     DOI: 10.1046/j.1365-2133.2003.05420.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study.

Authors:  Catherine S Thomson; Sarah Woolnough; Matthew Wickenden; Sara Hiom; Chris J Twelves
Journal:  BMJ       Date:  2010-03-18

Review 2.  Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis.

Authors:  Mathieu Boniol; Philippe Autier; Peter Boyle; Sara Gandini
Journal:  BMJ       Date:  2012-07-24

3.  Implications of lessons learned from tobacco control for tanning bed reform.

Authors:  Craig Sinclair; Jennifer K Makin
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.